Clarivate Plc
Clarivate Plc (CLVT) Covered Calls
Clarivate Plc trades in the Information Technology Services industry with an IV Rank of 85.32%, high versus the past year. CLVT's highest covered call setup is the $2.50 strike expiring Dec 18, 2026, sorted by theoretical annualized return. It's 7.76% out of the money with 37 days to expiration, a 9.91% return until expiration, and a 97.80% theoretical annualized return. Across the setups shown, annualized returns run from 43.37% to 97.80% at strikes between $2.50 and $2.50, with 37 to 156 days to expiration, as of Nov 11, 2026.
Read more
Running CLVT covered calls helps you generate income from Clarivate Plc shares you already own, turning a long stock position into a yield producing asset. A covered call means holding the underlying stock and selling a call option against it, collecting premium in exchange for capping upside at the strike. Use our scanner to find the best CLVT covered calls in real time and filter for the strikes, expiries, and premiums that fit your strategy.
A covered call pairs limited risk with a clear income profile. If CLVT stays below the strike at expiration, you keep the premium and the shares. If it rises above, you deliver the stock at the strike and still pocket the premium. Selling CLVT covered calls works best when implied volatility is elevated, since richer premiums improve the risk reward. Key inputs include strike selection relative to delta, days to expiration, annualized return, and probability of assignment, all of which determine whether a given CLVT covered call is worth writing.
Clarivate Plc, an information services and analytics company, provides structured information and analytics for discovery, protection, and commercialization of scientific research, innovations, and brands. It offers Web of Science products and services, such as Web of Science, InCites, Journal Citation Reports, EndNote, ScholarOne, Converis, Publons, and Kopernio to organizations that plan, fund, implement, and utilize research; and Life Sciences products, including Cortellis and Newport Integrity for pharmaceutical and biotechnology companies to support research, market intelligence, and competitive monitoring in connection with the development and commercialization of new drugs.
| 2026-12-18 | 37 | 2.50 | 7.76 | 0.05 | 0.20 | 23.00 | 9.91 | 97.80 | -2.16 | +0.41 | 1,387 | 0.15 |
| 2027-04-16 | 156 | 2.50 | 7.76 | 0.25 | 0.50 | 43.00 | 18.53 | 43.37 | -10.78 | +0.54 | 1,552 | 0.25 |
As of Nov 11, 2026
Prices move. This one stays.Lock in 5 years at a special price and save $1,503. Ending soon.See the Black Friday deal →Stock Statistics
- IndustryInformation Technology Services
- SectorTechnology
- IV Rank85.32% High
- Market cap (M$)1,491
- 52 weeks high-39.79%
- 52 weeks low64.08%
- Analyst recommendationHold
2.80 - Target price$2.65
13.73% above the current stock price - Dividend—
- Payout ratio—
- Earnings date2026-11-03
- P/E—
- Future P/E3.41
- EPS (ttm)-0.60
- EPS growth next 5 years4.20%
As of Nov 13, 2026